Initiator Pharma AS (OSTO:INIT) Loans Receivable: kr0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:INIT Initiator Pharma AS OSTO:INIT
24 GF Score
Price kr2.50
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS Loans Receivable?

Initiator Pharma AS OSTO:INIT -3.47% 24 Loans Receivable is kr0.00 Mil as of Mar. 2026. GuruFocus rates OSTO:INIT with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

Initiator Pharma AS's Loans Receivable for the quarter that ended in Mar. 2026 was kr0.00 Mil.

Initiator Pharma AS Loans Receivable Related Terms

Initiator Pharma AS Loans Receivable Historical Data

* Premium members only.

The historical data trend for Initiator Pharma AS's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Initiator Pharma AS Loans Receivable Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Initiator Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:INIT
24GF Score
Initiator Pharma AS OSTO:INIT
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of kr0.00 Mil mean?
Initiator Pharma AS (OSTO:INIT) has a Loans Receivable of kr0.00 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Initiator Pharma AS and its competitors.
Is Initiator Pharma AS's Loans Receivable too high?
Initiator Pharma AS's current Loans Receivable is kr0.00 Mil. Overall, Initiator Pharma AS has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Initiator Pharma AS's Loans Receivable compare to VRTX and REGN?
Initiator Pharma AS's Loans Receivable of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Biotechnology company?
A good Loans Receivable depends on the Biotechnology industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Initiator Pharma AS and its competitors. Initiator Pharma AS's current Loans Receivable is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Initiator Pharma AS stock overvalued right now?
Initiator Pharma AS (OSTO:INIT) has a current Loans Receivable of kr0.00 Mil. The current Loans Receivable is kr0.00 Mil. Initiator Pharma AS's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Initiator Pharma AS (OSTO:INIT), the current Loans Receivable is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
24GF Score

Get the complete analysis for OSTO:INIT

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.50
Price